Global leader in clinical trial payment automation experiences a 3-year growth of 133% as a result of increasing industry demand for financial and administrative workflow efficiencies
King of Prussia, PA – August 16, 2022 – Greenphire, the global leader in financial lifecycle management for clinical trials, today announced that it has been named to the 2022 Inc. 5000 list, marking the ninth time it has been recognized for its sustained growth in the market. The Inc. 5000 list ranks the nation’s fastest-growing private companies in a celebration of their leadership and entrepreneurialism.
As sponsors, CROs and sites continue to seek ways to provide the best possible patient experience, Greenphire has seen momentous growth across its two participant-focused solutions – ClinCard and ConneX. ClinCard is the most widely accepted and adopted clinical trial participant reimbursement technology in the industry, removing barriers to trial participation for millions of patients world-wide.
Despite travel challenges associated with COVID, ConneX, Greenphire’s comprehensive travel service designed specifically to support trial participants, has also continued to grow globally. The total itineraries and participants Greenphire supported increased by 36% and 52%, respectively over the past 12 months. Greenphire continues to expand its in-country travel support, boosting feet-on-the-ground assistance in key clinical trial regions, such as South America, Scandinavia, and APAC.
Keeping sites on track and satisfied remains a top priority for sponsors, driving interest for Greenphire’s site payment, and budget offerings – eClinicalGPS and EnvisiX.
eClinicalGPS, the most advanced investigator site payment solution, is used by top sponsors and CRO organizations across 75 countries. Meanwhile, Greenphire’s most recently launched solution, EnvisiX, continues to gain momentum in the market – delivering robust, up-to-date fair market value data accompanied by an intuitive budget development workflow to accelerate study startup for clinical trials around the world.
“The events over the past few years have accelerated the industry’s need for innovative solutions to drive efficiency and connectivity across the clinical trial lifecycle,” said Jim Murphy, CEO, Greenphire. “I am proud to lead an organization that is dedicated to bettering the way clinical trials are conducted – from increasing patient convenience, accessibility and diversity to reducing site burden and improving overall financial transparency.”
Greenphire will be honored at the Inc. 5000 Conference and Gala, which will be held October 19-21, 2022 at the JW Marriott Phoenix Desert Ridge Resort & Spa in Phoenix.
About Greenphire
Greenphire is the leader in global clinical trial financial process automation. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire’s EnvisiXTM, eClinicalGPS®, ClinCard® and ConneX® solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.
Media Contact:
Alyson Kuritz
alyson@0to5.com
(908) 892-7149
